ICU MEDICAL INC/DE

ICUI

$3.51B

Mid Cap

NASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaSAN CLEMENTE15.0K employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

ICUI News

Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

How ICUI's past catalysts played out

earningsMay 2025+6%earningsMay 2023+14%earningsAug 2022-12%earningsFeb 2022+6%earningsMay 2021-5%earningsMay 2020-9%earningsNov 2019+6%earningsNov 2018-11%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is ICU MEDICAL INC/DE's next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for ICU MEDICAL INC/DE (ICUI) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track ICUI biotech catalysts?→

Add ICUI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ICU MEDICAL INC/DE's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply